These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20944110)

  • 1. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
    Kuramitsu Y; Taba K; Ryozawa S; Yoshida K; Zhang X; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2010 Sep; 30(9):3367-72. PubMed ID: 20944110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.
    Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2010 Jul; 30(7):2539-43. PubMed ID: 20682980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells.
    Suenaga S; Kuramitsu Y; Wang Y; Baron B; Kitagawa T; Akada J; Tokuda K; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2013 Nov; 33(11):4821-6. PubMed ID: 24222118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells.
    Kuramitsu Y; Suenaga S; Wang Y; Tokuda K; Kitagawa T; Tanaka T; Akada J; Maehara S; Maehara Y; Nakamura K
    Anticancer Res; 2013 Aug; 33(8):3133-6. PubMed ID: 23898070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative proteomic analysis of two stress-management strategies in pancreatic cancer.
    Baron B; Fujioka T; Kitagawa T; Maehara S; Maehara Y; Nakamura K; Kuramitsu Y
    Cancer Genomics Proteomics; 2015; 12(2):83-7. PubMed ID: 25770192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.
    Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Mori-Iwamoto S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Chemotherapy; 2011; 57(1):12-6. PubMed ID: 21124027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.
    Kuramitsu Y; Wang Y; Kitagawa T; Tokuda K; Akada J; Tokunaga M; Nakamura K
    Anticancer Res; 2015 Jul; 35(7):3861-5. PubMed ID: 26124331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.
    Mori-Iwamoto S; Kuramitsu Y; Ryozawa S; Mikuria K; Fujimoto M; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
    Int J Oncol; 2007 Dec; 31(6):1345-50. PubMed ID: 17982661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
    Yoshida K; Kuramitsu Y; Murakami K; Ryozawa S; Taba K; Kaino S; Zhang X; Sakaida I; Nakamura K
    Anticancer Res; 2011 Jun; 31(6):2103-8. PubMed ID: 21737628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells.
    Chen YW; Liu JY; Lin ST; Li JM; Huang SH; Chen JY; Wu JY; Kuo CC; Wu CL; Lu YC; Chen YH; Fan CY; Huang PC; Law CH; Lyu PC; Chou HC; Chan HL
    Mol Biosyst; 2011 Nov; 7(11):3065-74. PubMed ID: 21894339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses.
    Liu QH; Zhao CY; Zhang J; Chen Y; Gao L; Ni CY; Zhu MH
    Mol Med Rep; 2012 Oct; 6(4):767-73. PubMed ID: 22858734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
    Tokunaga M; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
    Anticancer Res; 2015 Nov; 35(11):6063-7. PubMed ID: 26504030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
    Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
    Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.
    Suenaga S; Kuramitsu Y; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2014 Jan; 34(1):141-6. PubMed ID: 24403454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells.
    Kuhara K; Tokuda K; Kitagawa T; Baron B; Tokunaga M; Harada K; Terasaki M; Uehara O; Ohta T; Takai R; Hamada JI; Kobayashi M; Shimo T; Nagayasu H; Kuramitsu Y
    Anticancer Res; 2018 Nov; 38(11):6107-6111. PubMed ID: 30396925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
    Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
    Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proteomic profiling of gemcitabine resistance in pancreatic cancer cell lines.
    Mori-Iwamoto S; Kuramitsu Y; Ryozawa S; Taba K; Fujimoto M; Okita K; Nakamura K; Sakaida I
    Mol Med Rep; 2008; 1(3):429-34. PubMed ID: 21479428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro.
    Takata T; Ishigaki Y; Shimasaki T; Tsuchida H; Motoo Y; Hayashi A; Tomosugi N
    Oncol Rep; 2012 Dec; 28(6):1968-76. PubMed ID: 22961650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells.
    Shimada T; Nanimoto Y; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
    In Vivo; 2018; 32(4):759-763. PubMed ID: 29936456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents.
    Klanova M; Lorkova L; Vit O; Maswabi B; Molinsky J; Pospisilova J; Vockova P; Mavis C; Lateckova L; Kulvait V; Vejmelkova D; Jaksa R; Hernandez F; Trneny M; Vokurka M; Petrak J; Klener P
    Mol Cancer; 2014 Jun; 13():159. PubMed ID: 24972933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.